Literature DB >> 30580306

IgA nephropathy with diffuse alveolar haemorrhage.

Shinichi Miyazaki1, Akiko Hattori2, Yasumasa Kuno1, Takuya Ikeda1.   

Abstract

Immunoglobulin (Ig)A nephropathy is the most common cause of primary glomerulonephritis worldwide. While IgA nephropathy has been associated with a variety of other diseases, pulmonary complications are extremely rare. A 58-year-old man presented with a 2-week history of fever and exertional dyspnoea. A chest imaging revealed bilateral consolidation predominantly in upper lungs. Laboratory findings showed elevated serum creatinine with proteinuria and haematuria. Flexible bronchoscopy revealed diffuse alveolar haemorrhage, and IgA nephropathy was confirmed on a renal biopsy. He received prednisone with good effect. This case highlights the need to consider IgA nephropathy in the differential diagnosis of pulmonary renal syndrome. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; respiratory medicine

Mesh:

Substances:

Year:  2018        PMID: 30580306      PMCID: PMC6350714          DOI: 10.1136/bcr-2018-227382

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Glomerular IgA deposition in liver disease.

Authors:  S Pouria; J Feehally
Journal:  Nephrol Dial Transplant       Date:  1999-10       Impact factor: 5.992

Review 2.  IgA nephropathy.

Authors:  James V Donadio; Joseph P Grande
Journal:  N Engl J Med       Date:  2002-09-05       Impact factor: 91.245

3.  Landmark publication from The American Journal of the Medical Sciences: The significance of certain pulmonary lesions in relation to the etiology of influenza.

Authors:  Ernest W Goodpasture
Journal:  Am J Med Sci       Date:  2009-08       Impact factor: 2.378

4.  Pulmonary hemorrhage associated with Henoch-Schöenlein purpura in an adult patient primary diagnosed of IgA nephropathy.

Authors:  Takashi Tani; Ryuji Arima; Tomohiro Kaneko; Hiroki Hayashi; Kyoko Tsuruta; Akira Shimizu; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2014-07-22

Review 5.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

Authors:  J C Davin; I J Ten Berge; J J Weening
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

Review 6.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Authors:  Hernán Trimarchi; Jonathan Barratt; Daniel C Cattran; H Terence Cook; Rosanna Coppo; Mark Haas; Zhi-Hong Liu; Ian S D Roberts; Yukio Yuzawa; Hong Zhang; John Feehally
Journal:  Kidney Int       Date:  2017-03-22       Impact factor: 10.612

7.  Glomerular IgA deposits in patients with celiac disease.

Authors:  A Pasternack; P Collin; J Mustonen; T Reunala; I Rantala; K Laurila; A M Teppo
Journal:  Clin Nephrol       Date:  1990-08       Impact factor: 0.975

Review 8.  Pulmonary-renal syndromes: an update for respiratory physicians.

Authors:  Colm McCabe; Quentin Jones; Aikaterini Nikolopoulou; Chris Wathen; Raashid Luqmani
Journal:  Respir Med       Date:  2011-10       Impact factor: 3.415

Review 9.  HIV-associated IgA nephropathy--a post-mortem study.

Authors:  H Beaufils; C Jouanneau; C Katlama; V Sazdovitch; J J Hauw
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

10.  Evidence-based clinical practice guidelines for IgA nephropathy 2014.

Authors:  Yukio Yuzawa; Ryohei Yamamoto; Kazuo Takahashi; Ritsuko Katafuchi; Makoto Tomita; Yoshihide Fujigaki; Hiroshi Kitamura; Masashi Goto; Takashi Yasuda; Mitsuhiro Sato; Maki Urushihara; Shuji Kondo; Shoji Kagami; Yoshinari Yasuda; Hiroyuki Komatsu; Miki Takahara; Yasuaki Harabuchi; Kenjiro Kimura; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2016-08       Impact factor: 2.801

View more
  1 in total

1.  Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.

Authors:  Quentin Binet; Selda Aydin; Jean-Philippe Lengele; Jean-François Cambier
Journal:  J Nephrol       Date:  2020-09-01       Impact factor: 3.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.